Dual clinical studies reveal statistically meaningful benefits for patients with MSA, highlighting a leap forward for disease-modifying treatment …
Dual clinical studies reveal statistically meaningful benefits for patients with MSA, highlighting a leap forward for disease-modifying treatment …
Botensilimab and balstilimab combinations deliver unprecedented tumor responses across multiple cancer types, fueling optimism for harder-to-treat colorectal, breast, …
In a world-first, an infant with a fatal genetic disorder receives a custom, in vivo CRISPR therapy, showcasing …
Breakthroughs in personalized therapies and AI-driven tools are reshaping how cancer is diagnosed and treated, promising better outcomes …
New research unveiled at the American Association for Cancer Research meeting points to promising treatments for head and …
Phase 2 study for Caliway’s CBL-514 highlights significant progress for Dercum’s disease, a rare and painful condition with …
New trial presents and preclinical readouts set to shape the oncology landscape
Phase III ASCENT-04/KEYNOTE-D19 trial reveals meaningful PFS improvement with a novel antibody-drug conjugate/immunotherapy combo
Enhertu combo shows promise in metastatic breast cancer while Arvinas reveals hopeful data on a novel lymphoma proteolysis …
FDA greenlights two major therapies offering new hope for patients with IgA nephropathy and giant cell arteritis